✦ LIBER ✦

Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea

✍ Scribed by Park, Yongsoon; Lee, AeRi; Shim, Seung-Cheol; Lee, Ji Hyun; Choe, Jung-Yoon; Ahn, Hongyup; Choi, Chan Bum; Sung, Yoon Kyoung; Bae, Sang Cheol

Book ID: 120074397
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 315 KB
Volume: 24
Category: Article
ISSN: 0955-2863
DOI: 10.1016/j.jnutbio.2012.11.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of dietary supplementation w

The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

✍ G. L. NIELSEN; K. L. FAARVANG; B. S. THOMSEN; K. L. TEGLBJÆRG; L. T. JENSEN; T. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

Effect of folic or folinic acid suppleme

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight–week, multicenter, randomized, double-blind, placebo-controlled study

✍ Annelies E. Van Ede; Roland F. J. M. Laan; Maarten J. Rood; Tom W. J. Huizinga; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

Certolizumab pegol plus methotrexate is

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two–week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Edward Keystone; Désireé Van Der Heijde; David Mason Jr.; Robert Landewé; Ronald 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

Effect of n-3 polyunsaturated fatty acid

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

✍ GISSI-HF investigators 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 156 KB

A 24-Week, Randomized, Double-Blind, Pla

A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis

✍ Genovese, Mark C. (author);Cohen, Stanley B. (author);Wofsy, David (author);Wein 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB

A 24-Week, Randomized, Double-Blind, Pla

✍ Genovese, Mark C. (author);Cohen, Stanley B. (author);Wofsy, David (author);Wein 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB